Research database
SVF Research Library
Search 52,792 real PubMed studies on SVF and adipose-derived stem cells — 36 matching records.
36 results — page 1 of 2
- Level BClinical TrialPubMed
Mesenchymal Stromal Cell-Based Therapy: A Promising Approach for Autoimmune Diseases.
Clinical Trial on Chronic Inflammation, Immune Modulation, Autoimmune Research, published in Clin Rev Allergy Immunol (2025) — summary generated from the PubMed abstract.
- 2025
Clin Rev Allergy Immunol - Level CProspective StudyPubMed
Interleukin-27-adipose-derived mesenchymal stromal cell-based gene therapy attenuates inflammation in lipopolysaccharide-induced acute respiratory distress syndrome.
Prospective Study on Chronic Inflammation, Immune Modulation, published in Stem Cell Res Ther (2025) — summary generated from the PubMed abstract.
- 2025
Stem Cell Res Ther1 citations - Level CProspective StudyPubMed
Comparison of biological properties of human adipose tissue-derived mesenchymal stem/ stromal cells from healthy and diabetic donors: consequences for cell-based medicinal product development.
Prospective Study on Osteoarthritis, Type 2 Diabetes, Cardiovascular Disease, published in Cardiovasc Diabetol (2025) — summary generated from the PubMed abstract.
- 2025
Cardiovasc Diabetol - Level BClinical TrialPubMed
Interleukins and interferons in mesenchymal stromal stem cell-based gene therapy of cancer.
Clinical Trial on Systemic / IV, published in Cytokine Growth Factor Rev (2024) — summary generated from the PubMed abstract.
- 2024
Cytokine Growth Factor Rev - Level BClinical TrialEurope PMC
Mesenchymal Stromal Cell-Based Products: Challenges and Clinical Therapeutic Options
Clinical Trial, published in Int J Mol Sci (2024) — summary generated from the PubMed abstract.
- 2024
Int J Mol Sci20 citations - Level DNarrative ReviewEurope PMC
Role of Mesenchymal Stem/Stromal Cells in Head and Neck Cancer-Regulatory Mechanisms of Tumorigenic and Immune Activity, Chemotherapy Resistance, and Therapeutic Benefits of Stromal Cell-Based Pharmacological Strategies
Narrative Review, published in Cells (2024) — summary generated from the PubMed abstract.
- 2024
Cells12 citations - Level CProspective StudyPubMed
Acceptability of Allogeneic Mesenchymal Stromal Cell-Based Tissue Engineering for the Treatment of Periodontitis: A Qualitative Study in France.
Prospective Study with a reported sample of 4, published in Int Dent J (2024) — summary generated from the PubMed abstract.
- 2024
- n = 4
Int Dent J - Level DNarrative ReviewEurope PMC
Genetically modified mesenchymal stromal cells: a cell-based therapy offering more efficient repair after myocardial infarction
Narrative Review on Cardiovascular Disease, Scar, Chronic Inflammation, Immune Modulation, published in Stem Cell Res Ther (2024) — summary generated from the PubMed abstract.
- 2024
Stem Cell Res Ther8 citations - Level DNarrative ReviewEurope PMC
Multipotent mesenchymal stromal/stem cell-based therapies for acute respiratory distress syndrome: current progress, challenges, and future frontiers
Narrative Review on Chronic Inflammation, Immune Modulation, published in Braz J Med Biol Res (2024) — summary generated from the PubMed abstract.
- 2024
Braz J Med Biol Res3 citations - Level DNarrative ReviewEurope PMC
Combined cell-based therapy strategies for the treatment of Parkinson's disease: focus on mesenchymal stromal cells
Narrative Review on Neuroinflammation, published in Neural Regen Res (2023) — summary generated from the PubMed abstract.
- 2023
Neural Regen Res23 citations - Level DNarrative ReviewEurope PMC
Mesenchymal Stem/Stromal Cell-Based Therapies in Systemic Rheumatic Disease: From Challenges to New Approaches for Overcoming Restrictions
Narrative Review on Immune Modulation, Autoimmune Research, published in Int J Mol Sci (2023) — summary generated from the PubMed abstract.
- 2023
Int J Mol Sci11 citations - Level DNarrative ReviewEurope PMC
Management of Rheumatoid Arthritis: Possibilities and Challenges of Mesenchymal Stromal/Stem Cell-Based Therapies
Narrative Review on Chronic Inflammation, Immune Modulation, Autoimmune Research, published in Cells (2023) — summary generated from the PubMed abstract.
- 2023
Cells17 citations - Level CProspective StudyPubMed
Assessment of mesenchymal stem/stromal cell-based therapy in K/BxN serum transfer-induced arthritis.
Prospective Study on Immune Modulation, Autoimmune Research, published in Front Immunol (2022) — summary generated from the PubMed abstract.
- 2022
Front Immunol - Level DNarrative ReviewEurope PMC
Mesenchymal Stromal Cell-Based Therapy for Dry Eye: Current Status and Future Perspectives
Narrative Review on Chronic Inflammation, published in Cell Transplant (2022) — summary generated from the PubMed abstract.
- 2022
Cell Transplant18 citations - Level DLaboratory StudyPubMed
Comparable in vitro Function of Human Liver-Derived and Adipose Tissue-Derived Mesenchymal Stromal Cells: Implications for Cell-Based Therapy.
Laboratory Study with a reported sample of 6 on Immune Modulation, published in Front Cell Dev Biol (2021) — summary generated from the PubMed abstract.
- 2021
- n = 6
Front Cell Dev Biol - Level BClinical TrialEurope PMC
Harnessing the ECM Microenvironment to Ameliorate Mesenchymal Stromal Cell-Based Therapy in Chronic Lung Diseases
Clinical Trial on Immune Modulation, published in Front Pharmacol (2021) — summary generated from the PubMed abstract.
- 2021
Front Pharmacol14 citations - Level DNarrative ReviewPubMed
Allogenic Use of Human Placenta-Derived Stromal Cells as a Highly Active Subtype of Mesenchymal Stromal Cells for Cell-Based Therapies.
Narrative Review on Chronic Inflammation, Immune Modulation, published in Int J Mol Sci (2021) — summary generated from the PubMed abstract.
- 2021
Int J Mol Sci - Level DNarrative ReviewEurope PMC
Mesenchymal stem/stromal cell-based therapy for the treatment of rheumatoid arthritis: An update on preclinical studies
Narrative Review on Immune Modulation, Autoimmune Research, published in EBioMedicine (2021) — summary generated from the PubMed abstract.
- 2021
EBioMedicine53 citations - Level ASystematic ReviewEurope PMC
Clinical applications of mesenchymal stromal cell-based therapies for pulmonary diseases: An Update and Concise Review
Systematic Review on Immune Modulation, published in Int J Med Sci (2021) — summary generated from the PubMed abstract.
- 2021
Int J Med Sci26 citations - Level DNarrative ReviewEurope PMC
Is there a place for mesenchymal stromal cell-based therapies in the therapeutic armamentarium against COVID-19?
Narrative Review with a reported sample of 19 on Immune Modulation, published in Stem Cell Res Ther (2021) — summary generated from the PubMed abstract.
- 2021
- n = 19
Stem Cell Res Ther19 citations - Level BClinical TrialEurope PMC
Current Status of Cell-Based Therapies for COVID-19: Evidence From Mesenchymal Stromal Cells in Sepsis and ARDS
Clinical Trial, published in Front Immunol (2021) — summary generated from the PubMed abstract.
- 2021
Front Immunol25 citations - Level DLaboratory StudyEurope PMC
A Fibrin Coating Method of Polypropylene Meshes Enables the Adhesion of Menstrual Blood-Derived Mesenchymal Stromal Cells: A New Delivery Strategy for Stem Cell-Based Therapies
Laboratory Study on Chronic Inflammation, Immune Modulation, published in Int J Mol Sci (2021) — summary generated from the PubMed abstract.
- 2021
Int J Mol Sci7 citations - Level BClinical TrialPubMed
Mesenchymal Stromal Cell-Based Therapy-An Alternative to Arthroplasty for the Treatment of Osteoarthritis? A State of the Art Review of Clinical Trials.
Clinical Trial with a reported sample of 1325 on Knee Osteoarthritis, Osteoarthritis, published in J Clin Med (2020) — summary generated from the PubMed abstract.
- 2020
- n = 1325
J Clin Med8 citations - Level DAnimal StudyPubMed
Placenta-derived multipotent mesenchymal stromal cells: a promising potential cell-based therapy for canine inflammatory brain disease.
Animal Study on Neuroinflammation, Chronic Inflammation, Immune Modulation, published in Stem Cell Res Ther (2020) — summary generated from the PubMed abstract.
- 2020
Stem Cell Res Ther
In-depth reviewed studies (full Thai translation)
Evidence system- Level ARandomized Controlled Trial
Cell-based versus corticosteroid injections for knee pain in osteoarthritis: a randomized phase 3 trial
A multicentre randomized trial in 480 knee osteoarthritis patients comparing SVF, BMAC and umbilical cord MSCs against corticosteroid injection. At 12 months no cell product outperformed the steroid control.
- 2023
- United States
- n = 480
- Level AMeta-analysis
Intra-articular Injection of Autologous Adipose-Derived Stem Cells or Stromal Vascular Fractions: Are They Effective for Patients With Knee Osteoarthritis? A Systematic Review With Meta-analysis of Randomized Controlled Trials
Pooled five RCTs comparing ADSC/SVF injection with placebo or hyaluronic acid, finding significant pain and function improvement at 6 and 12 months.
- 2023
- South Korea
- Level AMeta-analysis
Rapid-acting pain relief in knee osteoarthritis: autologous-cultured adipose-derived mesenchymal stem cells outperform stromal vascular fraction: a systematic review and meta-analysis
Analysed 31 studies with 1,406 patients: cultured ADMSCs reduced pain from month 3, whereas SVF reached significance only at 12 months.
- 2024
- South Korea
- n = 1406